Literature DB >> 22327302

Dyspepsia: organic versus functional.

Pantelis Oustamanolakis1, Jan Tack.   

Abstract

Dyspepsia is the medical term for difficult digestion. It consists of various symptoms in the upper abdomen, such as fullness, discomfort, early satiation, bloating, heartburn, belching, nausea, vomiting, or pain. The prevalence of dyspepsia in the western world is approximately 20% to 25%. Dyspepsia can be divided into 2 main categories: "organic" and "functional dyspepsia" (FD). Organic causes of dyspepsia are peptic ulcer, gastroesophageal reflux disease, gastric or esophageal cancer, pancreatic or biliary disorders, intolerance to food or drugs, and other infectious or systemic diseases. Pathophysiological mechanisms underlying FD are delayed gastric emptying, impaired gastric accommodation to a meal, hypersensitivity to gastric distension, altered duodenal sensitivity to lipids or acids, altered antroduodenojenunal motility and gastric electrical rhythm, unsuppressed postprandial phasic contractility in the proximal stomach, and autonomic nervous system-central nervous system dysregulation. Pathogenetic factors in FD are genetic predisposition, infection from Helicobacter pylori or other organisms, inflammation, and psychosocial factors. Diagnostic evaluation of dyspepsia includes upper gastrointestinal endoscopy, abdominal ultrasonography, gastric emptying testing (scintigraphy, breath test, ultrasonography, or magnetic resonance imaging), and gastric accommodation evaluation (magnetic resonance imaging, ultrasound, single-photon emission computed tomography, and barostat). Antroduodenal manometry can be used for the assessment of the myoelectrical activity of the stomach, whereas sensory function can be evaluated with the barostat, tensostat, and satiety test. Management of FD includes general measures, acid-suppressive drugs, eradication of H. pylori, prokinetic agents, fundus-relaxing drugs, antidepressants, and psychological interventions. This review presents an update on the diagnosis of patients presenting with dyspepsia, with an emphasis on the pathophysiological and pathogenetic mechanisms of FD and the differential diagnosis with organic causes of dyspepsia. The management of uninvestigated and FD, as well as the established and new pharmaceutical agents, is also discussed.

Entities:  

Mesh:

Year:  2012        PMID: 22327302     DOI: 10.1097/MCG.0b013e318241b335

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  32 in total

1.  Inhibition of gastric perception of mild distention by omeprazole in volunteers.

Authors:  Akihito Iida; Hiroshi Kaneko; Toshihiro Konagaya; Yasushi Funaki; Kentaro Tokudome; Shinya Izawa; Yasuhiro Tamura; Mari Mizuno; Naotaka Ogasawara; Makoto Sasaki; Kunio Kasugai
Journal:  World J Gastroenterol       Date:  2012-10-21       Impact factor: 5.742

Review 2.  Role of metabotropic glutamate receptors in the regulation of pancreatic functions.

Authors:  Tanja Babic; R Alberto Travagli
Journal:  Biochem Pharmacol       Date:  2013-12-16       Impact factor: 5.858

Review 3.  Dietary and lifestyle factors in functional dyspepsia.

Authors:  Christine Feinle-Bisset; Fernando Azpiroz
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-01-08       Impact factor: 46.802

Review 4.  The microbiota-gut-brain axis in functional gastrointestinal disorders.

Authors:  Giada De Palma; Stephen M Collins; Premysl Bercik
Journal:  Gut Microbes       Date:  2014-06-12

Review 5.  Bloating and functional gastro-intestinal disorders: where are we and where are we going?

Authors:  Paola Iovino; Cristina Bucci; Fabrizio Tremolaterra; Antonella Santonicola; Giuseppe Chiarioni
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

6.  EAES recommendations for the management of gastroesophageal reflux disease.

Authors:  Karl Hermann Fuchs; Benjamin Babic; Wolfram Breithaupt; Bernard Dallemagne; Abe Fingerhut; Edgar Furnee; Frank Granderath; Peter Horvath; Peter Kardos; Rudolph Pointner; Edoardo Savarino; Maud Van Herwaarden-Lindeboom; Giovanni Zaninotto
Journal:  Surg Endosc       Date:  2014-05-02       Impact factor: 4.584

Review 7.  The Gut Microbiome in Adult and Pediatric Functional Gastrointestinal Disorders.

Authors:  Andrea Shin; Geoffrey A Preidis; Robert Shulman; Purna C Kashyap
Journal:  Clin Gastroenterol Hepatol       Date:  2018-08-25       Impact factor: 11.382

8.  The Diagnosis and Treatment of Functional Dyspepsia.

Authors:  Ahmed Madisch; Viola Andresen; Paul Enck; Joachim Labenz; Thomas Frieling; Michael Schemann
Journal:  Dtsch Arztebl Int       Date:  2018-03-30       Impact factor: 5.594

9.  Prevalence of functional dyspepsia and its subgroups in patients with eating disorders.

Authors:  Antonella Santonicola; Monica Siniscalchi; Pietro Capone; Serena Gallotta; Carolina Ciacci; Paola Iovino
Journal:  World J Gastroenterol       Date:  2012-08-28       Impact factor: 5.742

10.  Gastrointestinal symptoms and associated factors in Chinese patients with functional dyspepsia.

Authors:  Jiao Yu; Shi Liu; Xiu-Cai Fang; Jun Zhang; Jun Gao; Ying-Lian Xiao; Li-Ming Zhu; Fen-Rong Chen; Zhao-Shen Li; Pin-Jin Hu; Mei-Yun Ke; Xiao-Hua Hou
Journal:  World J Gastroenterol       Date:  2013-08-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.